Skip to main content
PLOS One logoLink to PLOS One
. 2025 May 20;20(5):e0320858. doi: 10.1371/journal.pone.0320858

Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: a study protocol for a randomized controlled trial

Joana Borges 1,2,*,#, Diogo Monteiro 1,3,#, Fernanda M Silva 4,5,#, Miguel Jacinto 1,3,#, Tiago Pastilha 6,#, Pedro Duarte-Mendes 7,8,*,#
Editor: Shabnam ShahAli9
PMCID: PMC12091758  PMID: 40392887

Abstract

Background

Chronic low back pain (CLBP) is a disease with significant functional, emotional and social impact. Several interventions are proposed for its management and exercise is one of main, land-based or water-based. This study describes a randomized controlled trial that will analyze the effect of a combined aquatic and land-based exercise program compared to an aquatic-based program on pain, functional incapacity and quality of life in adults with CLBP. Additionally, it will analyze the effects of exercise cessation in the same outcomes.

Methods and design

A blind randomized controlled trial will be developed with a 1:1 allocation ratio. Around 30 adults with mechanical CLBP will be randomly allocated in two groups. The experimental group (ALG) will complete an aquatic and land-based exercise program and control group (AG) will carry out only an aquatic program, both for 8 weeks. Participants will be assessed with Visual Analogue Scale, Oswestry Disability Index, Short-Form 36, Tampa Scale of Kinesiophobia-13 and Modified-Modified Schober Test, collected at baseline (M0), after 8 weeks (M1) and 4 weeks after the end of the intervention (M2).

Discussion

This study may provide a relevant contribution to understand the potential effect of a combined land and aquatic exercise program on pain, functional disability, fear of movement, quality of life and lumbar mobility. The results may provide important information for CLBP management.

Trial registration

This trial is registered with ClinicalTrials.gov (registration number: NCT06641570; date of registration: October 14, 2024).

Introduction

Chronic low back pain (CLBP) is considered as “pain tension or stiffness localized below the costal margin and above the inferior gluteal folds”, lasting more than 12 weeks [13]. It can be distinguished in two main categories: specific, when the cause is attributed to a pathology or structural lesion and non-specific (accounts for about 90% of cases), when it is not possible to determine a recognizable known cause [3]. Low physical activity levels, obesity, smoking and high stress constitute risk factors for its occurrence [4].

This is one of the most frequent public health problems with a high prevalence in the world population [5]. According to GBD 2021 [3], CLBP in 2020 affected around 619 million people worldwide, and it is estimated that more than 80% of the population will have at least one episode of low back pain in their life [5]. The prevalence of CLBP is 4.2% in people aged between 24 and 39 years old and 19.6% between 20 and 59 years old, noting that women have CLBP more frequently than men [6]. Therefore, CLBP has a strong impact on functionality, well-being and quality of life, leading to limitations in social and work life of who suffers from this health condition, with economy implications and direct and indirect annual costs associated with health care resources usage [79].

These justify the need to study therapeutic strategies to manage this chronic condition. Some guidelines for the management of CLBP recommend physical exercise as a first-line treatment to reduce pain and disability, with programs duration superior than twenty hours for higher benefits, not mentioning the most appropriate type or intensity [1012]. A systematic review with meta-analysis conducted by Hayden et al. [13] concluded that exercise can provide benefits in pain and disability caused by CLBP, compared to controls without treatment or with placebo intervention. Additionally, the same authors added that few studies report side effects associated with exercise.

On the other hand, prolonged periods of physical inactivity negatively impact the recovery from pain and functional disability caused by CLBP, so it is recommended that these individuals remain physically active [14]. Some authors suggest a variety of exercise types for managing CLBP, including aerobic exercise (from light to high intensity) [15,16], muscle strengthening exercises [17,18], and flexibility exercises [19]. Furthermore, Psycharakis et al. [20] highlight core stability exercises, as they recruit lumbar spine and pelvis stabilizing muscles. These exercises aim to counteract the decreased spine and pelvis neuromotor control and the muscle weakness of the abdominal and hip muscles observed in individuals with CLBP [21,22]. However, there is no consensus on the most suitable type of exercise, making it a controversial topic that requires further scientific research [23,24].

The reduction of lumbar spine stability due to decreased core muscle activity can lead to CLBP, with some studies indicating that activation exercises for the abdominal and spinal extensor muscles may play an important role in this condition management [2527]. In turn, decreased lumbar spinal joint mobility and reduced flexibility in muscles such as the spinal extensors, hip flexors, and hamstrings may also contribute to CLBP persistence, justifying the inclusion of stretching exercises in exercise programs [26,28].

Another proposed modality is aquatic exercise, which utilizes the properties and characteristics of water for physical activity, aiming to reduce pain, strengthen muscles, and promote relaxation, among other benefits [29,30]. Thus, aquatic exercise is of particular interest, as the unique properties of water, such as buoyancy and hydrostatic pressure, reduce joint stress on the spine and other joints, and enhance balance, mobility, and pain control [29,31,32]. Additionally, the aquatic environment allows individuals to perform movements that are typically difficult or impossible on land [33]. Beyond this, continuous movement of the limbs against the resistance of the water leads to increased muscle strength and cardiovascular benefits [3436]. A systematic review by Ma et al. [37] found that aquatic exercise programs were effective in reducing pain and improving quality of life and functional capacity in patients with CLBP, compared to other interventions or control groups with no intervention. Some authors argue that the buoyancy achieved during aquatic exercise can reduce the impact of gravity on the body, decreasing joint stress during exercise and pain [3840]. Other researchers found that aquatic may be more beneficial than land-based programs in lumbar pain, health-related quality of life, and functional disability [4143]. In contrast, Yalfani et al. [44] compared a Pilates exercise program performed in water with the same program conducted on land and found that both significantly reduced pain and dysfunction, with no significant differences between the programs. In light of these differences in the literature, no study has yet investigated whether there is an additional effect from combining land-based and water-based exercises on the same variables, compared to an exclusive water exercise program.

Moreover, few authors have investigated the effects of cessation of exercise [45,46]. Mujika & Padilla [46] argue that detraining can be divided into two study periods: short-term, less than 4 weeks, and long-term, more than 4 weeks. Therefore, Toraman & Ayceman [47] found that after 4 weeks of interruption following a 9-week aerobic, strength, and flexibility training program, conducted 3 times a week, participants showed a reduction in performance levels on various functional tests, standing out the Chair Sit and Reach, compared to the end of the intervention, although the changes were not statistically significant. Thus, the impact of aquatic exercise, core stability exercise, and trunk and lower limb stretching cessation on individuals with CLBP remains unclear.

This trial aims to assess the effect of a combined aquatic and land-based exercise program compared to an aquatic program on pain, functional disability, and quality of life in adults with CLBP. Secondary objectives include investigating the effects on lumbar mobility and fear of movement, as well as the impact of training cessation on these variables 4 weeks after the end of the intervention. We hypothesize that combined aquatic and land-based exercise decreases significantly pain, and functional disability, and increases quality of life in adults with CLBP.

Materials and methods

Study design

This investigation will follow a quantitative model and a randomized controlled trial (RCT) study design, according to the Statement guidelines for standard protocol items in clinical trials (SPIRIT) and the Consolidated Standards of Reporting Trials (CONSORT) statement [48,49]. S1 Fig shows the SIPRIT checklist. This study protocol is registered in the Clinicaltrials.gov ID: NCT06641570 (date of registration: October 14, 2024).

Participants

The study sample will consist of both gender Portuguese participants, over 18 years, with CLBP lasting three months or longer and with an intensity of 3 or higher on the visual analogue scale (VAS) at rest. Individuals who refuse to participate or do not provide informed consent will be excluded, as well as those with pain radiating to the lower limb, recent pregnancy or childbirth (less than 8 weeks ago) [50], ongoing physical therapy treatments, severe rheumatological, neurological, neoplastic, cardiovascular diseases, or other conditions that could prevent full participation in the intervention, a history of spinal surgery, inflammatory, infectious, or malignant spinal diseases, and psychiatric disorders that may affect adherence and symptom assessment [4143].

The sample will be randomly divided into two groups: the experimental group, which will undergo the aquatic and land-exercise program (ALG), and the control group, which will perform the aquatic-exercise program (AG).

The required sample size was calculated using the G*Power software (3.1.9.4; Heinrich Heine University Düsseldorf, DE), based on a study with 65 participants by Dundar et al. [42] and corroborated by other studies [5153]. The aim was to detect differences in pain intensity (VAS) between the aquatic exercise program group and the control group (land exercise), with an effect size of 1.079, α=0.05, and a power of 80%. The total sample size needed to achieve the objective will be 30 participants (15 in each group).

Thus, the study should start with an additional 15% of the planned sample size for each group to account for potential dropouts and as well as adopt cognitive-behavioral strategies to reduce dropout rates, such as setting flexible and participant-driven goals or providing positive and individualized feedback [54,55].

Ethics

According to the Helsinki Declaration protocol (1964) [56], written informed consent will be obtained from the participants. All participants receive a signed copy. Each participant will receive a unique coded alphanumeric identification ensuring data anonymity in accordance with the General Data Protection Regulation (GDPR), following Regulation (EU) 2016/679 of the European Parliament of April 27, 2016, and the Personal Data Protection Law, according to Law No. 58/2019 of August 8. The files that connect alphanumeric codes to participants identifying information will be stored in a separate locked file protected by a password access system, only known by the principal investigator [48].

This study will be based on the ethical standards required in scientific research and was submitted for review by the Ethics Committee of the Polytechnic University of Leiria and approved on March 27, 2024 (reference: CE/IPLEIRIA/47/2024). Study procedures, protocol risks voluntary character of participation and expected results will be explained to the participants. The right to withdraw without any prejudice or consequence will be ensured.

Intervention

The intervention will take place over 8 weeks at the Municipal Pool of Paião, located in Figueira da Foz, Portugal. The AG will conduct the aquatic exercise program, while the ALG will carry out both aquatic and land-based exercise programs. The intervention will begin after a one-week washout period, during which participants will cease any additional physical exercise, which they will maintain throughout the intervention weeks.

To monitor the intensity of the interventions, Borg CR-10 scale will be used. This is a tool to rate dyspnea and/or perceived exertion (RPE) experienced by an individual. The scale consists of a numerical list with 10 points (0–10), an adaptation of the original scale (6–20), that assesses and monitors the intensity/severity of shortness of breath/fatigue. Its use requires explaining that “0" means not experiencing dyspnea/fatigue at the moment and that “10" means the worst dyspnea/fatigue they have ever experienced or the worst imaginable dyspnea/fatigue [57,58]. This instrument will not be used during the assessment moments before and after the exercise programs but only to monitor the intensity during the sessions of both aquatic and land-based exercise programs. This scale is validated for monitoring dyspnea and fatigue, showing an excellent correlation with heart rate (r=0.92) and VO2 (r=0.92–0.93) and moderate reliability (ICC=0.50–0.66) [59].

Participants will be encouraged to maintain their daily activities as usual outside of the study. The participants may not participate in any other exercise programs.

Aquatic-exercise program.

This intervention will consist of an aquatic-exercise program (Table 1), administered by a physiotherapist. It will include 16 sessions, twice a week, over 8 weeks at a water temperature between 32–34 ∘ C. Each session will be conducted in groups of 8–12 patients and will last about 45 minutes. The aquatic exercise sessions will include a warm-up phase (5 minutes): walking forwards, sideways, and backwards; a training phase (35 minutes): active range of motion exercises (10 minutes) for the spine, upper and lower limbs; aerobic exercises (5 minutes) with jumps and static running at various speeds; muscle strengthening (10–15 minutes), (8–12 repetitions), 1–2 sets, 8–10 exercises including hip flexion, extension, adduction, and abduction, knee flexion and extension, knee cycling, shoulder flexion, extension, and abduction, elbow flexion, extension, and pronation-supination, squatting, and stretching exercises (5–10 minutes) for the neck, trunk, and limbs; and a relaxation/cool-down phase (5 minutes): including lying supine and low-impact exercises such as slow walking, squatting, and standing [20,37,38,41,42]. For participants who cannot complete any exercise due to difficulty or discomfort, a modified version of each exercise will be offered. The load progression will be managed using auxiliary equipment, including flotation devices, plates, balls, pull-buoys, and dumbbells, according to each participant’s RPE on the Borg CR-10 scale.

Table 1. Aquatic-exercise program.
Type Frequency and duration Intensity
Week 1–4 Week 5–8
Aquatic exercise: aerobic, resistance, and flexibility training performed in water. 2 times per week. Session duration: 40–45 min (warm-up phase: 5 min, training phase: 30–35 min; and relaxation/cool-down phase: 5 min). Warm-up phase: Warm-up phase:
Low-intensity aerobic exercise: walking forwards, sideways, and backwards. RPE: 3–4 (Borg CR-10 Scale). Low-intensity aerobic exercise: walking forwards, sideways, and backwards. RPE: 3–4 (Borg CR-10 Scale).
Training phase: Training phase:
Active range of motion exercises: spine, upper and lower limbs. RPE: 3–4 (Borg CR-10 Scale). Active range of motion exercises: spine, upper and lower limbs. RPE: 3–4 (Borg CR-10 Scale).
Moderate-intensity aerobic exercise: jumps and static running at various speeds. RPE: 5–6 (Borg CR-10 Scale). Moderate-to-high intensity aerobic exercise: jumps and static running at various speeds. RPE: 6–8 (Borg CR-10 Scale).
Muscle strengthening exercises: 8–12 reps, 1 set, 8–10 exercises (hip flexion, extension, adduction, and abduction, knee flexion and extension, knee cycling, shoulder flexion, extension, and abduction, elbow flexion, extension, and pronation-supination, squatting). RPE: 5–6 (Borg CR-10 Scale). Muscle strengthening exercises: 8–12 reps, 2 sets, 8–10 exercises (hip flexion, extension, adduction, and abduction, knee flexion and extension, knee cycling, shoulder flexion, extension, and abduction, elbow flexion, extension, and pronation-supination, squatting). RPE: 6–7 (Borg CR-10 Scale).
Static stretching exercises: stretching for 30–45s, 1 rep, 8–10 exercises (neck, trunk, and limbs). RPE: 3–4 (Borg CR-10 Scale). Static stretching exercises: stretching for 45–60s, 1 rep, 8–10 exercises (neck, trunk, and limbs). RPE: 3–4 (Borg CR-10 Scale).
Relaxation/cool-down phase: Relaxation/cool-down phase:
Low-intensity exercise: slow walking, squatting and standing. RPE: 2–4 (Borg CR-10 Scale). Low-intensity exercise: slow walking, squatting and standing. RPE: 2–4 (Borg CR-10 Scale).
Diaphragmatic breathing/ Floating. RPE: 0–2 (Borg CR-10 Scale). Diaphragmatic breathing/ Floating. RPE: 0–2 (Borg CR-10 Scale).

Notes: min, minutes; RPE, rate of perceived exertion; reps, repetitions; s, seconds.

Land-exercise program.

This program will include specific land-based exercises (Table 2, guided by a physiotherapist. This intervention will include 8 sessions in 8 weeks, once a week, on a different day from the aquatic exercise program. Each session will last between 25 to 35 minutes and will be divided into two components: core stability exercises and stretching of the trunk and lower limbs [60]. Core stability exercises (15–20 minutes): these will consist of isometric exercises which contraction was maintained for 7–8 seconds, 8–12 repetitions, 1 set, with brief rest intervals of 3 seconds between repetitions and 30 seconds to 1 minute between exercises [60,61]. Exercises will include abdominal hollowing, side bridge (both sides), supine extension bridge, lower limb extension from prone (both sides), and alternate arm and leg raise from quadruped. Intensity will increase gradually by reducing rest time between exercises and increasing repetitions, based on participants’ performance. Participants will be instructed to contract and hold their abdominal muscles while maintaining normal breathing patterns [62]. Stretching exercises (10–15 minutes): participants will perform muscle stretching exercises, holding the maximum stretch for 30 seconds to 1 minute, and returning to the original position, followed by 5–10 seconds of rest. Each exercise will be repeated two to three times [63]. Stretches will target the hamstrings, iliopsoas, piriformis, and tensor fasciae latae. Participants will be instructed to minimize tension in other body muscles and maintain their usual breathing pattern during stretching [6467].

Table 2. Land-exercise program.
Type Frequency and duration Intensity
Week 1–4 Week 5–8
Core stability exercises: abdominal hollowing, side bridge (both sides), supine extension bridge, lower limb extension from prone (both sides), and alternate arm and leg raise from quadruped, performed in dry land. 1 time per week. Session duration: 25–35 min Isometric strength exercises: contraction held for 7–8s, 8–10 reps, 1 set. Isometric strength exercises: Contraction held for 9–10s, 10–12 reps, 1 set.
(Core stability exercises: 15–20 min, and stretching exercises: 10–15 min). Rest between reps: 3s Rest between reps: 3s
Rest between exercises: 1min. Rest between exercises: 30s.
RPE: 5–6 (Borg CR-10 Scale) RPE: 6–7 (Borg CR-10 Scale)
Stretching exercises: stretching the hamstrings, iliopsoas, piriformis, and tensor fasciae latae, performed in dry land. Static stretching exercises: stretching for 30–45s. Static stretching exercises: stretching for 45–60s.
2 reps. 3 reps.
Rest between reps: 5–10s. Rest between reps: 5–10s.
RPE: 5–6 (Borg CR-10 Scale) RPE: 5–6 (Borg CR-10 Scale)

Notes: min, minutes; s, seconds; reps, repetitions; RPE, rate of perceived exertion.

Procedures

The experimental procedures will be conducted at the Municipal Pool of Paião, in Figueira da Foz. The research team will consist of a principal investigator, an examiner, a data analyst, and two intervention administrators. The SPIRIT schedule of the study protocol is presented in Fig 1.

Fig 1. Schedule of enrolment, interventions and assessments.

Fig 1

Feasibility study.

To assess the need for any adjustments in the experimental procedures and evaluate the feasibility of the clinical study methodology, a trial of the data collection protocol will be conducted with two to three individuals who meet the study’s eligibility criteria.

Sample selection and characterization.

Participant recruitment has begun in September 2024 and is expected to be completed in January 2025. Participants will be invited and recruited to the study through posters, which will include a brief explanation of the study’s aims and procedures. Interested individuals will complete a written selection and characterization questionnaire, and the principal investigator will provide detailed information about all procedures involved in the study.

Randomization and Blinding.

Participants who meet eligibility criteria will be given an alphanumeric code to maintain data confidentiality and anonymity. Participants will be randomly assigned to either ALG or AG, with a 1:1 allocation. Randomization will be performed by the principal investigator using a block randomization method generated by a computer program to ensure equal sample sizes in both groups. The block size will not be disclosed to maintain concealment. Participants will be informed of their group allocation (ALG or AG) via telephone contact. The principal investigator will not be actively involved in the intervention, data collection or data analysis. Randomization will only be known to the physiotherapists responsible for the intervention and the principal investigator. The examiner will evaluate participants before the intervention and after 8 weeks of intervention, ensuring blinding to group allocation, and participants will be asked not to disclose this information to the examiner. Each intervention will have a physiotherapist responsible for its execution, who will be instructed not to reveal participants’ group allocation to other research team members. Both data collector and data analyst will be unaware of the participants’ group distribution and will also be considered blinded. Only the principal investigator will have full knowledge of the entire research flow.

Data Collection.

After enrollment, participants will complete three evaluation phases: before the intervention (M0), after the intervention (M1), and 4 weeks after the end of the intervention (M2). Data collection started in November 2024 and is expected to be completed in April 2025. During data collection, participants will start each data collection session by filling out the questionnaires (Oswestry Disability Index, MOS Short Form Health Survey 36 Item, and Tampa Scale of Kinesiophobia-13) and the Visual Analog Scale for pain at rest, during movement, and at night, which will take approximately 30 minutes. Following this, the physiotherapist responsible for the assessment will measure weight and height, and then assess lumbar spine mobility using the Modified-Modified Schober Test, taking the best of three measurements. To standardize data collection, each participant will be asked to stand barefoot on a paper where the outline of their feet will be drawn to ensure consistent positioning across all measurements. This procedure will be repeated three times, with a 30-second break between repetitions. Participants will be instructed to place their feet at hip-width apart and their upper limbs relaxed along the body in the test starting position [68,69]. Fig 2 shows the study design with key moments of the intervention and data collection.

Fig 2. Study design with key moments of the intervention and data collection.

Fig 2

Outcome measures

Sample Selection and Characterization Questionnaire.

A questionnaire will be developed to select and characterize the study sample. It will collect personal data (age and sex), anthropometric data (height and weight), symptom duration, comorbidities, and professional status.

Primary outcomes

Visual Analogue Scale (VAS). The VAS is a unidimensional measure of pain intensity used to track its progression over time. This instrument consists of a 100-millimeter line, presented either vertically or horizontally, with an initial value of 0 indicating “No Pain" and an end value of 10 representing “Worst Pain." Participants are asked to mark a perpendicular line on the scale that corresponds to their level of pain. The scale is recorded on a single-use sheet of paper, and the value is obtained by measuring the distance from the origin (0) to the mark [70]. The VAS is a validated tool for assessing the intensity of CLBP, with moderate to strong construct validity (0.50–0.81), moderate to excellent test-retest reliability [Intraclass Correlation Coefficient (ICC) = 0.49–0.90], and a standard error of measurement (SEm) of 0.1% [71]. Additionally, the minimal clinically important difference (MCID) for this instrument is 20mm for CLBP [72].

Oswestry Disability Index – version 2.0 (ODI). The ODI is a tool used to measure and assess the disability caused by low back pain. It consists of 10 questions, each rated on a Likert scale from 0 to 5, where 0 represents no dysfunction and 5 represents the highest level of dysfunction. The final score is expressed as a percentage, indicating the level of disability experienced by the individual with low back pain: 0%–20% (minimal disability); 21%–40% (moderate disability); 41%–60% (severe disability); 61%–80% (very severe disability); 81%–100% (exaggerated symptoms) [73,74]. This instrument has been translated and validated for the Portuguese population, showing a good correlation with the MOS Short Form Health Survey 36 (r=0.59 to –0.75) and excellent internal consistency (Cronbach’s α = 0.95) and reproducibility (ICC = 0.90) [75,76]. The MCID for this questionnaire was established at 10% [72,77].

MOS Short Form Health Survey 36 Item v2 (SF-36 v2). The SF-36 v2 questionnaire is an assessment tool primarily designed to measure and evaluate the health status and quality of life of populations and individuals, whether they have health conditions or not. It consists of 36 items, rated on a scale from 1 to 5 (Likert scale). The questionnaire is divided into 8 dimensions (physical functioning, physical role limitations, bodily pain, general health perceptions, energy/vitality, social functioning, emotional role limitations and mental health), which can be grouped into two components (physical health and mental health). Scores for each dimension are presented on a positively oriented scale from 0 (worst health state) to 100 (best health state) [78]. The instrument was previously validated and translated for the Portuguese population, demonstrating good content validity (r>0.401) and moderate to excellent levels of internal consistency (Cronbach’s α = 0.60–0.87) and test-retest reliability (ICC = 0.45-0.84) across its various domains [79,80]. For this instrument, the MCID has been established at 6 for mental health and 14 for physical health [81].

Secondary outcomes

Tampa Scale of Kinesiophobia-13 (TSK-13). The TSK-13 is a simple tool designed to quantify fear of movement or (re)injury. The questionnaire consists of 13 items, rated on a 4-point Likert scale (strongly disagree, disagree, agree, and strongly agree), with a final score ranging from 13 to 52 points [82]. The final classification of fear of movement can be categorized as subclinical (13–22), mild (23–32), moderate (33–42), and severe (43–52) [83]. The questionnaire has been translated for the Portuguese population, with construct validity established through its correlation with the VAS for pain intensity (r=0.691) and confidence in movement (r=0.772). The instrument shows excellent reliability (ICC = 0.94–0.98) and internal consistency (Cronbach’s α = 0.82) [84]. The MCID for this questionnaire has been established at 5.5 points [85].

Modified-Modified Schober Test (MMST). The MMST is a test originally designed to determine whether there is a reduction in lumbar spine range of motion due to various health conditions such as CLBP. It has subsequently been used to measure the effects of therapeutic interventions on lumbar mobility [86]. To perform this test, the participant should be in an upright position so that the examiner can mark both Posterior Superior Iliac Spines (PSIS) using a skin marker, then draw a horizontal line between them and mark a point at the intersection of this line with the spine (center of both marks). Next, the examiner should mark a second point 15 cm above the first. The participant is then instructed to bend the trunk as if trying to “touch their toes”, and the examiner should measure the distance between the upper and lower lines again. An increase of less than 5 cm in the measured distance indicates a decrease in lumbar spine range of motion [87]. The MMST is a validated test for individuals with CLBP, showing a moderate correlation (r=0.67) with the gold standard metric (X-ray) and excellent reliability, specifically in interclass correlations (r=0.91) and intraclass correlations (r=0.95) [88]. For this test, the minimal detectable difference is 1 cm [89].

Anthropometry. Body mass will be assessed using a portable scale (Inbody 270, USA) with an accuracy of 0.1kg, while participants will be asked to wear minimal clothes. Height will be measured using a portable stadiometer (SECA Bodymeter 208, Germany), with an accuracy of 1 millimeter, following standardized procedures [90]. Body Mass Index (BMI) will be calculated using the formula: BMI=(weight/height2) [91]. Skeletal muscle mass (kg), fat mass (kg), bone mineral mass (%), and body fat (%) will be assessed using the tetrapolar bioimpedance (Inbody 270, USA). The impedance measurements will be performed according to the literature and manufactory recommendations [92].

Adverse events

During the procedures, participants may experience some adverse events and should be aware of the potential risks during both the assessment phase and the intervention. To address this, a cardiovascular risk assessment will be conducted to contraindicate the performance of physical exercise/activity according to the American College of Sports Medicine flowchart, and the PAR-Q questionnaire will be administered. Participants classified as high risk will be excluded from the study to minimize the risk associated with physical exercise. For the remaining risk categories, the risk of a cardiovascular event is null or reduced [13]. Participants will be instructed to regularly check their skin and contact the principal investigator if they experience a rash, redness, itching, or any other sign of an allergic reaction, although such adverse reactions are rare [37]. Thus, the physiotherapist will record any adverse events that may occur by asking participants if they have experienced any health issues (injuries, pain, etc.) since the previous session. All adverse events will be reviewed by the research team and appropriately referred for clinical treatment or rest.

Participant adherence

Individual participation in each exercise session (both land and aquatic) will be recorded by the physiotherapist responsible for the intervention with a “0" if the participant does not attend or a “1" if the participant is present and participates. Strategies will be adopted to promote adherence to the exercises, including text messages and/or email [93]. If a participant misses two consecutive sessions, he/she will be contacted to resume the exercise sessions, as lack of adherence may affect the results obtained [94]. At the end of the interventions, participants who do not achieve at least 80% of the total sessions will be excluded from data analysis [91,95].

Statistical analysis

An inspection of the data will be made for missing values or univariate outliers. A priori power analysis through G*Power (3.1.9.7) [96] and ANOVA repeated measures, within-between interaction will be use to determine the required sample size considering the following input parameters: (effect size f = 0.4; α err prob = 0.05; statistical power = 0.95) [97]. Data analyses will be performed using SPSS Statistics version 29.0 (SPSS Inc., IBM Company, Chicago, Illinois, USA). Descriptive statistics (mean ± SD) will be performed for all variables in the analysis. Assuming data normality, a 2×3 within-between interaction factorial ANOVA will be applied for intra and inter group comparisons. To control for Type I errors, multiple comparisons will be adjusted using the Bonferroni correction (i.e., alpha level divided by the number of tests) as suggested by several authors (e.g., Ho, 2014) [98].The magnitude of the global effect size will be calculated using Cohen’s effect size. The Cohen’s d effect size is categorized according to the following criteria: d = < 0.20 (small), 0.21–0.79 (medium) and > 0.80 (large) [99101]. Significance level set at ρ 0.05. Full statistical analysis and results are expected to be completed in May 2025.

Discussion

This study will investigate and compare the effectiveness of a water-based and land-based exercise program versus a solely water-based program on pain levels, functional disability, quality of life, lumbar mobility, and fear of movement in adults with CLBP. Additionally, an effort will be made to assess the effect of the cessation of exercise on the mentioned variables, 4 weeks after the end of the intervention. A minimum of 15 participants per group is expected to ensure the calculated sample power. However, a higher number of participants should be ensured, as it is known that approximately 50% of participants drop out within the first six months due to personal characteristics, environmental factors, or issues with the programs [55]. On the other hand, in order to maintain the methodological quality of the study, according to the Physiotherapy Evidence Database (PEDro) Scale, the variables should be measured at the end in more than 85% of the participants who were initially randomized [102].

Previously, an author conducted a RCT with 12 participants (6 in the experimental group and 6 in the control group) in which the effect of an aquatic exercise program (experimental) was compared with that of a land-based program (control) on the level of pain and mobility of the lumbar spine [41]. At the end of the interventions (6 weeks), no statistically significant differences were observed in pain (VAS) (ρ=0.523), nor in the lumbar spine mobility test (Modified-Modified Schober Test) (ρ=0.56). Another author also studied in a RCT the differences between a group of participants who engaged in an aquatic exercise program (experimental) and a group who engaged in a land-based program (control) with 65 individuals with LBP (32 in the experimental group and 33 in the control group) [42]. After 4 weeks of intervention, statistically significant differences were observed favoring the experimental intervention in the ODI score (ρ < 0.001) and in the physical function (ρ < 0.001) and physical performance (ρ < 0.001) domains of the SF-36 questionnaire. No statistically significant differences were found between the groups in rest pain, pain during movement, or nocturnal pain (VAS), in lumbar mobility test (Modified-Modified Schober Test), or in the remaining domains of the SF-36 questionnaire.

The study (RCT) with the most similar methodology was conducted with 66 participants (33 in each group) and aimed to examine the effect of an experimental aquatic and land-based exercise program compared to a control program of exclusively land-based (home-based) [43]. After two weeks of intervention, statistically significant differences were observed favoring the experimental intervention in pain: VAS at rest (ρ < 0.001), during exercise (ρ < 0.001), and overall in the lumbar spine (ρ < 0.001); in the ODI score (ρ = 0.045); and in the SF-36 domains of physical performance (ρ = 0.033), mental health (ρ = 0.021), pain (ρ = 0.014), and general health (ρ = 0.05). No statistically significant differences were found between the groups in the remaining domains of the SF-36 questionnaire or in the Modified-Modified Schober Test.

No study with a similar methodology has reported results for the TSK-13 questionnaire to date. Thus, it is challenging to predict the results of the study, as the methodologies differ and the sample sizes and intervention durations vary considerably among authors. It is not possible to project whether the group that will undertake the additional land-based exercise session will achieve better outcomes than the experimental group at the end of the intervention, in the studied variables. However, the variables most sensitive to the presented interventions appear to be pain, measured by VAS, functional disability measured by ODI, and some domains of the SF-36 related to pain and physical performance. These are likely to be the variables with the greatest variability at the end of the study. On the other hand, it is difficult to predict the trend of changes in the studied variables after 1 month of exercise cessation due to the lack of reference literature.

Thus, this study aims to provide implications for the practice and prescription of physical exercise and effective strategies that may contribute to potential benefits for individuals with LBP. Like all studies, this one will have some limitations: it will be impossible to fully control activities outside of the protocol, which may affect the studied variables either positively or negatively, and aquatic exercise limits the calculation of exercise intensity, which will be monitored only through perceived exertion.

Dissemination of results

Upon completion of the study, regardless of the direction and magnitude of the results, they will be published. The results will be communicated to the participants and their families, the scientific community, and the general public, through oral presentations and publications in recognized journals in the field.

Authorship of the manuscripts resulting from this study will be based on: significant contributions to the study conceptualization or design, formal analysis and/or interpretations of the data, and revising and editing the manuscript critically.

Supporting information

S1 File. Filled SPIRIT checklist.
pone.0320858.s001.doc (122.5KB, doc)

(DOC)

Acknowledgments

The authors would like to thank the organizations that collaborated in the development of the proposed study: ESECS-Polytechnic of Leiria, Department of Sports and Well-Being of Polytechnic Institute of Castelo Branco and Municipal Pool of Paião.

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

This work was funded by National Funds by FCT - Foundation for Science and Technology under the following project UID/04045: Research Center in Sports Sciences, Health Sciences, and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

References

  • 1.Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP. Low back pain. Lancet. 2021;398(10294):78–92. doi: 10.1016/S0140-6736(21)00733-9 [DOI] [PubMed] [Google Scholar]
  • 2.Violante FS, Mattioli S, Bonfiglioli R. Low-back pain. Handb Clin Neurol. 2015;131:397–410. doi: 10.1016/B978-0-444-62627-1.00020-2 [DOI] [PubMed] [Google Scholar]
  • 3.GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(e316–29):e316-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stevans JM, Delitto A, Khoja SS, Patterson CG, Smith CN, Schneider MJ, et al. Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care. JAMA Netw Open. 2021;4(2):e2037371. doi: 10.1001/jamanetworkopen.2020.37371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169(3):251–8. doi: 10.1001/archinternmed.2008.543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015; 49:1. doi: 10.1590/S0034-8910.2015049005874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Balagué F, Mannion AF, Pellisé F, Cedraschi C. Non-specific low back pain. Lancet. 2012;379(9814):482–91. doi: 10.1016/S0140-6736(11)60610-7 [DOI] [PubMed] [Google Scholar]
  • 8.Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8(1):8–20. doi: 10.1016/j.spinee.2007.10.005 [DOI] [PubMed] [Google Scholar]
  • 9. Vlaeyen JWS, Maher CG, Wiech K, Van Zundert J, Meloto CB, Diatchenko L, et al. Low back pain. Nat Rev Dis Primers. 2018;4(1):52. doi: 10.1038/s41572-018-0052-1 [DOI] [PubMed] [Google Scholar]
  • 10.Lavigny P, Kuntze S, Watson P, Underwood M, Ritchie G, Cotterell M. Low back pain: early management of persistent non-specific low back pain. 2009. [DOI] [PubMed]
  • 11.Savigny P, Watson P, Underwood M, Guideline Development Group. Early management of persistent non-specific low back pain: summary of NICE guidance. BMJ. 2009;338:b1805. doi: 10.1136/bmj.b1805 [DOI] [PubMed] [Google Scholar]
  • 12.WHO. guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings. World Health Organization. 2023. [PubMed] [Google Scholar]
  • 13.Hayden JA, Ellis J, Ogilvie R, Malmivaara A, van Tulder MW. Exercise therapy for chronic low back pain. Cochrane Database Syst Rev. 2021;9(9):CD009790. doi: 10.1002/14651858.CD009790.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.National Health Service. Back pain. NHS.UK. https://www.nhs.uk/Conditions/Back-pain/ 2022. Accessed 2024 July 13.
  • 15.Chan CW, Mok NW, Yeung EW. Aerobic exercise training in addition to conventional physiotherapy for chronic low back pain: a randomized controlled trial. Arch Phys Med Rehabil. 2011;92(10):1681–5. doi: 10.1016/j.apmr.2011.05.003 [DOI] [PubMed] [Google Scholar]
  • 16.Chatzitheodorou D, Kabitsis C, Malliou P, Mougios V. A pilot study of the effects of high-intensity aerobic exercise versus passive interventions on pain, disability, psychological strain, and serum cortisol concentrations in people with chronic low back pain. Phys Ther. 2007;87(3):304–12. doi: 10.2522/ptj.20060080 [DOI] [PubMed] [Google Scholar]
  • 17.Inani SB, Selkar SP. Effect of core stabilization exercises versus conventional exercises on pain and functional status in patients with non-specific low back pain: a randomized clinical trial. J Back Musculoskelet Rehabil. 2013;26(1):37–43. doi: 10.3233/BMR-2012-0348 [DOI] [PubMed] [Google Scholar]
  • 18.STANKOVIC A, LAZOVIC M, KOCIC M, DIMITRIJEVIC L, STANKOVIC I, ZLATANOVIC D, et al. Kronik Bel Ağrılı Hastalarda Güçlendirme ve Germe Egzersizlerine Ek Olarak Yapılan Lomber Stabilizasyon Egzersizleri Ağrıyı Azaltır ve Fonksiyonu Arttırır: Randomize Açık Klinik Çalışma. tftr. 2012;58(3):177–83. doi: 10.4274/tftr.22438 [DOI] [Google Scholar]
  • 19.Kuukkanen T, Mälkiä E. Effects of a three-month therapeutic exercise programme on flexibility in subjects with low back pain. Physiother Res Int. 2000;5(1):46–61. doi: 10.1002/pri.183 [DOI] [PubMed] [Google Scholar]
  • 20.Psycharakis SG, Coleman SGS, Linton L, Valentin S. The WATER study: Which AquaTic ExeRcises increase muscle activity and limit pain for people with low back pain?. Physiotherapy. 2022;116:108–18. doi: 10.1016/j.physio.2022.03.003 [DOI] [PubMed] [Google Scholar]
  • 21.D’hooge R, Hodges P, Tsao H, Hall L, Macdonald D, Danneels L. Altered trunk muscle coordination during rapid trunk flexion in people in remission of recurrent low back pain. J Electromyogr Kinesiol. 2013;23(1):173–81. doi: 10.1016/j.jelekin.2012.09.003 [DOI] [PubMed] [Google Scholar]
  • 22.Nourbakhsh MR, Arab AM. Relationship between mechanical factors and incidence of low back pain. J Orthop Sports Phys Ther. 2002;32(9):447–60. doi: 10.2519/jospt.2002.32.9.447 [DOI] [PubMed] [Google Scholar]
  • 23.Hayden JA, van Tulder MW, Tomlinson G. Systematic review: strategies for using exercise therapy to improve outcomes in chronic low back pain. Ann Intern Med. 2005;142(9):776–85. doi: 10.7326/0003-4819-142-9-200505030-00014 [DOI] [PubMed] [Google Scholar]
  • 24.Smith JA, Osborn M. Pain as an assault on the self: An interpretative phenomenological analysis of the psychological impact of chronic benign low back pain. Psychology & Health. 2007;22(5):517–34. doi: 10.1080/14768320600941756 [DOI] [Google Scholar]
  • 25.Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, De Cuyper HJ. CT imaging of trunk muscles in chronic low back pain patients and healthy control subjects. Eur Spine J. 2000;9(4):266–72. doi: 10.1007/s005860000190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gordon R, Bloxham S. A Systematic Review of the Effects of Exercise and Physical Activity on Non-Specific Chronic Low Back Pain. Healthcare (Basel). 2016;4(2):22. doi: 10.3390/healthcare4020022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Willson JD, Dougherty CP, Ireland ML, Davis IM. Core stability and its relationship to lower extremity function and injury. J Am Acad Orthop Surg. 2005;13(5):316–25. doi: 10.5435/00124635-200509000-00005 [DOI] [PubMed] [Google Scholar]
  • 28.Turci AM, Nogueira CG, Nogueira Carrer HC, Chaves TC. Self-administered stretching exercises are as effective as motor control exercises for people with chronic non-specific low back pain: a randomised trial. J Physiother. 2023;69(2):93–9. doi: 10.1016/j.jphys.2023.02.016 [DOI] [PubMed] [Google Scholar]
  • 29.Camilotti BM, Rodacki ALF, Israel VL, Fowler NE. Stature recovery after sitting on land and in water. Man Ther. 2009;14(6):685–9. doi: 10.1016/j.math.2009.03.007 [DOI] [PubMed] [Google Scholar]
  • 30.Cimbiz A, Bayazit V, Hallaceli H, Cavlak U. The effect of combined therapy (spa and physical therapy) on pain in various chronic diseases. Complement Ther Med. 2005;13(4):244–50. doi: 10.1016/j.ctim.2005.08.004 [DOI] [PubMed] [Google Scholar]
  • 31.Baena-Beato PÁ, Artero EG, Arroyo-Morales M, Robles-Fuentes A, Gatto-Cardia MC, Delgado-Fernández M. Aquatic therapy improves pain, disability, quality of life, body composition and fitness in sedentary adults with chronic low back pain. A controlled clinical trial. Clin Rehabil. 2014;28(4):350–60. doi: 10.1177/0269215513504943 [DOI] [PubMed] [Google Scholar]
  • 32.Bressel E, Dolny DG, Gibbons M. Trunk muscle activity during exercises performed on land and in water. Med Sci Sports Exerc. 2011;43(10):1927–32. doi: 10.1249/MSS.0b013e318219dae7 [DOI] [PubMed] [Google Scholar]
  • 33.Becker B, Cole A. Comprehensive aquatic therapy. 2004. [Google Scholar]
  • 34.Campbell JA, D’Acquisto LJ, D’Acquisto DM, Cline MG. Metabolic and cardiovascular response to shallow water exercise in young and older women. Med Sci Sports Exerc. 2003;35(4):675–81. doi: 10.1249/01.MSS.0000058359.87713.99 [DOI] [PubMed] [Google Scholar]
  • 35.Pöyhönen T, Sipilä S, Keskinen KL, Hautala A, Savolainen J, Mälkiä E. Effects of aquatic resistance training on neuromuscular performance in healthy women. Med Sci Sports Exerc. 2002;34(12):2103–9. doi: 10.1249/01.MSS.0000039291.46836.86 [DOI] [PubMed] [Google Scholar]
  • 36.Yozbatiran N, Yildirim Y, Parlak B. Effects of fitness and aquafitness exercises on physical fitness in patients with chronic low back pain. The Pain Clinic. 2004;16(1):35–42. doi: 10.1163/156856904322858684 [DOI] [Google Scholar]
  • 37.Ma J, Zhang T, He Y, Li X, Chen H, Zhao Q. Effect of aquatic physical therapy on chronic low back pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23(1):1050. doi: 10.1186/s12891-022-05981-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Abadi FH, Sankaravel M, Zainuddin FF, Elumalai G, Razli AI. The effect of aquatic exercise program on low-back pain disability in obese women. J Exerc Rehabil. 2019;15(6):855–60. doi: 10.12965/jer.1938688.344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Louw A, Puentedura EJ, Zimney K, Schmidt S. Know Pain, Know Gain? A Perspective on Pain Neuroscience Education in Physical Therapy. J Orthop Sports Phys Ther. 2016;46(3):131–4. doi: 10.2519/jospt.2016.0602 [DOI] [PubMed] [Google Scholar]
  • 40.Waller B, Lambeck J, Daly D. Therapeutic aquatic exercise in the treatment of low back pain: a systematic review. Clin Rehabil. 2009;23(1):3–14. doi: 10.1177/0269215508097856 [DOI] [PubMed] [Google Scholar]
  • 41.Bello AI, Kalu NH, Adegoke BOA, Agyepong-Badu S. hydrotherapy versus land-based exercises in the management of chronic low back pain: a comparative study. J Musculoskelet Res. 2010;13(04):159–65. doi: 10.1142/s0218957710002594 [DOI] [Google Scholar]
  • 42.Dundar U, Solak O, Yigit I, Evcik D, Kavuncu V. Clinical effectiveness of aquatic exercise to treat chronic low back pain: a randomized controlled trial. Spine (Phila Pa 1976). 2009;34(14):1436–40. doi: 10.1097/BRS.0b013e3181a79618 [DOI] [PubMed] [Google Scholar]
  • 43.Yücesoy H, Dönmez A, Atmaca-Aydın E, Yentür SP, Saruhan-Direskeneli G, Ankaralı H, et al. Effects of balneological outpatient treatment on clinical parameters and serum cytokine levels in patients with chronic low back pain: a single-blind randomized controlled trial. Int J Biometeorol. 2021;65(8):1367–76. doi: 10.1007/s00484-021-02109-w [DOI] [PubMed] [Google Scholar]
  • 44.Yalfani A, Raeisi Z, Koumasian Z. Effects of eight-week water versus mat pilates on female patients with chronic nonspecific low back pain: Double-blind randomized clinical trial. J Bodyw Mov Ther. 2020;24(4):70–5. doi: 10.1016/j.jbmt.2020.06.002 [DOI] [PubMed] [Google Scholar]
  • 45.Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res. 2004;57(4):391–8. doi: 10.1016/j.jpsychores.2004.04.002 [DOI] [PubMed] [Google Scholar]
  • 46.Mujika I, Padilla S. Detraining: loss of training-induced physiological and performance adaptations. Part I: short term insufficient training stimulus. Sports Med. 2000;30(2):79–87. doi: 10.2165/00007256-200030020-00002 [DOI] [PubMed] [Google Scholar]
  • 47.Toraman NF, Ayceman N. Effects of six weeks of detraining on retention of functional fitness of old people after nine weeks of multicomponent training. Br J Sports Med. 2005;39(8):565–8; discussion 568. doi: 10.1136/bjsm.2004.015586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1(2):100–7. doi: 10.4103/0976-500X.72352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Kalra B, Sawhney K, Kalra S. Management of thyroid disorders in pregnancy: Recommendations made simple. J Pak Med Assoc. 2017;67(9):1452–5. [PubMed] [Google Scholar]
  • 51.Assis MR, Silva LE, Alves AMB, Pessanha AP, Valim V, Feldman D, et al. A randomized controlled trial of deep water running: clinical effectiveness of aquatic exercise to treat fibromyalgia. Arthritis Rheum. 2006;55(1):57–65. doi: 10.1002/art.21693 [DOI] [PubMed] [Google Scholar]
  • 52.Hayden JA, van Tulder MW, Malmivaara A, Koes BW. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev. 2005;2005(3):CD000335. doi: 10.1002/14651858.CD000335.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;4(4):CD011279. doi: 10.1002/14651858.CD011279.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Collado-Mateo D, Lavín-Pérez AM, Peñacoba C, Del Coso J, Leyton-Román M, Luque-Casado A, et al. Key Factors Associated with Adherence to Physical Exercise in Patients with Chronic Diseases and Older Adults: An Umbrella Review. Int J Environ Res Public Health. 2021;18(4):2023. doi: 10.3390/ijerph18042023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Robison JI, Rogers MA. Adherence to exercise programmes. Recommendations. Sports Med. 1994;17(1):39–52. doi: 10.2165/00007256-199417010-00004 [DOI] [PubMed] [Google Scholar]
  • 56.World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. doi: 10.1001/jama.2013.281053 [DOI] [PubMed] [Google Scholar]
  • 57.Borg G. Borg’s perceived exertion and pain scales. 1st ed. ed. Champaign: Human Kinetics. 1998. [Google Scholar]
  • 58.Williams N. The Borg Rating of Perceived Exertion (RPE) scale. Occupational Medicine. 2017;67(5):404–5. doi: 10.1093/occmed/kqx063 [DOI] [Google Scholar]
  • 59.Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999;116(5):1208–17. doi: 10.1378/chest.116.5.1208 [DOI] [PubMed] [Google Scholar]
  • 60.Kim B, Yim J. Core Stability and Hip Exercises Improve Physical Function and Activity in Patients with Non-Specific Low Back Pain: A Randomized Controlled Trial. Tohoku J Exp Med. 2020;251(3):193–206. doi: 10.1620/tjem.251.193 [DOI] [PubMed] [Google Scholar]
  • 61.Erratum: The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain [Corrigendum]. J Pain Res. 2022;15:4075–6. doi: 10.2147/JPR.S402370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Saleh MSM, Botla AMM, Elbehary NAM. Effect of core stability exercises on postpartum lumbopelvic pain: A randomized controlled trial. J Back Musculoskelet Rehabil. 2019;32(2):205–13. doi: 10.3233/BMR-181259 [DOI] [PubMed] [Google Scholar]
  • 63.Han H-I, Choi H-S, Shin W-S. Effects of hamstring stretch with pelvic control on pain and work ability in standing workers. J Back Musculoskelet Rehabil. 2016;29(4):865–71. doi: 10.3233/BMR-160703 [DOI] [PubMed] [Google Scholar]
  • 64.Castellote-Caballero Y, Valenza MC, Puentedura EJ, Fernández-de-Las-Peñas C, Alburquerque-Sendín F. Immediate Effects of Neurodynamic Sliding versus Muscle Stretching on Hamstring Flexibility in Subjects with Short Hamstring Syndrome. J Sports Med (Hindawi Publ Corp). 2014;2014:127471. doi: 10.1155/2014/127471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Gulledge BM, Marcellin-Little DJ, Levine D, Tillman L, Harrysson OLA, Osborne JA, et al. Comparison of two stretching methods and optimization of stretching protocol for the piriformis muscle. Med Eng Phys. 2014;36(2):212–8. doi: 10.1016/j.medengphy.2013.10.016 [DOI] [PubMed] [Google Scholar]
  • 66.Umehara J, Ikezoe T, Nishishita S, Nakamura M, Umegaki H, Kobayashi T, et al. Effect of hip and knee position on tensor fasciae latae elongation during stretching: An ultrasonic shear wave elastography study. Clin Biomech (Bristol). 2015;30(10):1056–9. doi: 10.1016/j.clinbiomech.2015.09.007 [DOI] [PubMed] [Google Scholar]
  • 67.Wakefield CB, Cottrell GT. Changes in hip flexor passive compliance do not account for improvement in vertical jump performance after hip flexor static stretching. J Strength Cond Res. 2015;29(6):1601–8. doi: 10.1519/JSC.0000000000000794 [DOI] [PubMed] [Google Scholar]
  • 68.Amjad F, Mohseni Bandpei MA, Gilani SA, Arooj A. Reliability of modified-modified Schober’s test for the assessment of lumbar range of motion. J Pak Med Assoc. 2022;72(9):1755–9. doi: 10.47391/JPMA.4071 [DOI] [PubMed] [Google Scholar]
  • 69. Cidem M, Karacan I, Uludag M. Normal range of spinal mobility for healthy young adult Turkish men. Rheumatol Int. 2012;32(8):2265–9. doi: 10.1007/s00296-011-1953-4 [DOI] [PubMed] [Google Scholar]
  • 70.Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S240-52. doi: 10.1002/acr.20543 [DOI] [PubMed] [Google Scholar]
  • 71.Chiarotto A, Maxwell LJ, Ostelo RW, Boers M, Tugwell P, Terwee CB. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review. J Pain. 2019;20(3):245–63. doi: 10.1016/j.jpain.2018.07.009 [DOI] [PubMed] [Google Scholar]
  • 72.Ostelo RWJG, de Vet HCW. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol. 2005;19(4):593–607. doi: 10.1016/j.berh.2005.03.003 [DOI] [PubMed] [Google Scholar]
  • 73.Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther. 2002;82(1):8–24. doi: 10.1093/ptj/82.1.8 [DOI] [PubMed] [Google Scholar]
  • 74.Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66(8):271–3. [PubMed] [Google Scholar]
  • 75.Martins N. Adaptação cultural e linguística do Owestry low back pain disability index - ODI 2.0. Escola Superior de Tecnologia da Saúde de Coimbra. 2002.
  • 76.Pereira V. Validação intercultural do oswestry disability questionnaire (versão 2.0). 2003.
  • 77.Hägg O, Fritzell P, Nordwall A, Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J. 2003;12(1):12–20. doi: 10.1007/s00586-002-0464-0 [DOI] [PubMed] [Google Scholar]
  • 78.Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83. doi: 10.1097/00005650-199206000-00002 [DOI] [PubMed] [Google Scholar]
  • 79.Ferreira PL. Development of the Portuguese version of MOS SF-36. Part I. Cultural and linguistic adaptation. Acta Med Port. 2000;13(1–2):55–66. [PubMed] [Google Scholar]
  • 80.Ferreira PL. Development of the Portuguese version of MOS SF-36. Part II --Validation tests. Acta Med Port. 2000;13(3):119–27. [PubMed] [Google Scholar]
  • 81.Jayadevappa R, Cook R, Chhatre S. Minimal important difference to infer changes in health-related quality of life-a systematic review. J Clin Epidemiol. 2017; 89:188–98. doi: 10.1016/j.jclinepi.2017.06.009 [DOI] [PubMed] [Google Scholar]
  • 82.Miller RP, Kori SH, Todd DD. The Tampa Scale. The Clinical Journal of Pain. 1991;7(1):51. doi: 10.1097/00002508-199103000-00053 [DOI] [Google Scholar]
  • 83.Neblett R, Hartzell MM, Mayer TG, Bradford EM, Gatchel RJ. Establishing clinically meaningful severity levels for the Tampa Scale for Kinesiophobia (TSK-13). Eur J Pain. 2016;20(5):701–10. doi: 10.1002/ejp.795 [DOI] [PubMed] [Google Scholar]
  • 84.Cordeiro N, Pezarat-Correia P, Gil J, Cabri J. Portuguese Language Version of the Tampa Scale for Kinesiophobia [13 Items]. Journal of Musculoskeletal Pain. 2013;21(1):58–63. doi: 10.3109/10582452.2012.762966 [DOI] [Google Scholar]
  • 85.Monticone M, Ambrosini E, Rocca B, Foti C, Ferrante S. Responsiveness of the Tampa Scale of Kinesiophobia in Italian subjects with chronic low back pain undergoing motor and cognitive rehabilitation. Eur Spine J. 2016;25(9):2882–8. doi: 10.1007/s00586-016-4682-2 [DOI] [PubMed] [Google Scholar]
  • 86.Macrae IF, Wright V. Measurement of back movement. Ann Rheum Dis. 1969;28(6):584–9. doi: 10.1136/ard.28.6.584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Hershkovich O, Grevitt MP, Lotan R. Schober Test and Its Modifications Revisited-What Are We Actually Measuring? Computerized Tomography-Based Analysis. J Clin Med. 2022;11(23):6895. doi: 10.3390/jcm11236895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Tousignant M, Poulin L, Marchand S, Viau A, Place C. The Modified-Modified Schober Test for range of motion assessment of lumbar flexion in patients with low back pain: a study of criterion validity, intra- and inter-rater reliability and minimum metrically detectable change. Disabil Rehabil. 2005;27(10):553–9. doi: 10.1080/09638280400018411 [DOI] [PubMed] [Google Scholar]
  • 89.Sakulsriprasert P, Vachalathiti R, Vongsirinavarat M, Pichaisak W. Responsiveness of pain, active range of motion, and disability in patients with acute nonspecific low back pain. Hong Kong Physiotherapy Journal. 2011;29(1):20–4. doi: 10.1016/j.hkpj.2011.02.003 [DOI] [Google Scholar]
  • 90.Lohman T, Roche A. Anthropometric standardization reference manual. 1st ed. Human Kinetics. [Google Scholar]
  • 91.Ferreira JP, Duarte-Mendes P, Teixeira AM, Silva FM. Effects of combined training on metabolic profile, lung function, stress and quality of life in sedentary adults: A study protocol for a randomized controlled trial. PLoS One. 2022;17(2):e0263455. doi: 10.1371/journal.pone.0263455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Khalil SF, Mohktar MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors (Basel). 2014;14(6):10895–928. doi: 10.3390/s140610895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Connelly J, Kirk A, Masthoff J, MacRury S. The use of technology to promote physical activity in Type 2 diabetes management: a systematic review. Diabet Med. 2013;30(12):1420–32. doi: 10.1111/dme.12289 [DOI] [PubMed] [Google Scholar]
  • 94.Sherrington C, Tiedemann A, Fairhall N, Close JCT, Lord SR. Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations. N S W Public Health Bull. 2011;22(3–4):78–83. doi: 10.1071/NB10056 [DOI] [PubMed] [Google Scholar]
  • 95.Brellenthin AG, Lanningham-Foster LM, Kohut ML, Li Y, Church TS, Blair SN, et al. Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise (CardioRACE): Rationale, design, and methods. Am Heart J. 2019;217:101–11. doi: 10.1016/j.ahj.2019.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91. doi: 10.3758/bf03193146 [DOI] [PubMed] [Google Scholar]
  • 97.Flores G, Monteiro D, Silva F, Duarte-Mendes P. Heart rate variability activity in soccer athletes after a musculoskeletal injury. J Rehabil Med. 2024;56:jrm24969. doi: 10.2340/jrm.v56.24969 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Ho R. Handbook of univariate and multivariate data analysis with IBM SPSS. 2nd ed. ed. New York: CRC Press. 2014. [Google Scholar]
  • 99.Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. ed. New York: Lawrence Erlbaum Associates. 1988. [Google Scholar]
  • 100.Silva FM, Duarte-Mendes P, Carvalho E, Soares CM, Farinha C, Serrano J, et al. Effects of combined training during the COVID-19 pandemic on metabolic health and quality of life in sedentary workers: A randomized controlled study. Front Public Health. 2022;10:1040714. doi: 10.3389/fpubh.2022.1040714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Silva FM, Duarte-Mendes P, Ferreira JP, Carvalho E, Monteiro D, Massart A, et al. Changes in Metabolic and Inflammatory Markers after a Combined Exercise Program in Workers: A Randomized Controlled Trial. Med Sci Sports Exerc. 2024;56(11):2156–72. doi: 10.1249/MSS.0000000000003510 [DOI] [PubMed] [Google Scholar]
  • 102.Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–21. doi: 10.1093/ptj/83.8.713 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Shabnam ShahAli

2 Feb 2025

PONE-D-25-01668Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: A study protocol for a randomized controlled trialPLOS ONE

Dear Dr. Borges,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shabnam ShahAli, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have selected “Clinical Trial” as your article type. PLOS ONE requires that all clinical trials are registered in an appropriate registry (the WHO list of approved registries is at      https://www.who.int/clinical-trials-registry-platform/network/primary-registries" https://www.who.int/clinical-trials-registry-platform/network/primary-registries and more information on trial registration is at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/).

Please state the name of the registry and the registration number (e.g. ISRCTN or ClinicalTrials.gov) in the submission data and on the title page of your manuscript.

a) Please provide the complete date range for participant recruitment and follow-up in the methods section of your manuscript.

b) If you have not yet registered your trial in an appropriate registry, we now require you to do so and will need confirmation of the trial registry number before we can pass your paper to the next stage of review. Please include in the Methods section of your paper your reasons for not registering this study before enrolment of participants started. Please confirm that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”.

Please see http://journals.plos.org/plosone/s/submission-guidelines#loc-clinical-trials for our policies on clinical trials.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

“This work was funded by National Funds by FCT - Foundation for Science and 418

Technology under the following project UIDB/04045/2020 419

(https://doi.org/10.54499/UIDB/04045/2020).”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This work was funded by National Funds by FCT - Foundation for Science and Technology under the following project UIDB/04045/2020 (https://doi.org/10.54499/UIDB/04045/2020). The authors would like to thank the organizations that collaborated in the development of the proposed study: ESECS-Polytechnic of Leiria, Department of Sports and Well-Being of Polytechnic Institute of Castelo Branco and Municipal Pool of Pai˜ao”.

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This work was funded by National Funds by FCT - Foundation for Science and 418

Technology under the following project UIDB/04045/2020 419

(https://doi.org/10.54499/UIDB/04045/2020).”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. In the online submission form, you indicated that your data will be submitted to a repository upon acceptance.  We strongly recommend all authors deposit their data before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire minimal  dataset will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption.

7. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

8. We note that the original protocol file you uploaded contains a confidentiality notice indicating that the protocol may not be shared publicly or be published. Please note, however, that the PLOS Editorial Policy requires that the original protocol be published alongside your manuscript in the event of acceptance. Please note that should your paper be accepted, all content including the protocol will be published under the Creative Commons Attribution (CC BY) 4.0 license, which means that it will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution.

9. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Good protocol paper with enough information. However there are some points needs to modify.

firstly, I did not satisfy with your work novelty. Are the outcome measures the only things that show your paper novelty?

Second, did you upload SPIRIT checklist to editor board with each item completed?

Reviewer #2: I appreciate the opportunity to review this study. The authors have devoted significant time and effort to this study. I have provided some comments that should be addressed to improve the quality of the manuscript.

Introduction

1- Please add your specific hypotheses at the end of introduction.

Methods

2- The pre-specified outcome measures were not defined in terms of primary or secondary. Please define primary and secondary outcome measures in the manuscript.

3- The sample size should be calculated based on the pre-specified primary outcome. Did the authors consider the pain intensity (VAS) as the primary outcome in this study?

Reviewer #3: The manuscript has been accepted for publication following a comprehensive review. The reviewers found that it adheres to the journal's standards, with commendable methodology and data analysis.

Additionally, all required revisions have been properly addressed, enhancing the quality and clarity of the work.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Atieh Nazem

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 May 20;20(5):e0320858. doi: 10.1371/journal.pone.0320858.r003

Author response to Decision Letter 1


5 Feb 2025

Dear Professor Shabnam ShahAli,

My colleagues and I would like to express our gratitude for the opportunity to resubmit our manuscript, Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: A study protocol for a randomized controlled trial" by Joana Borges, Diogo Monteiro, Fernanda M. Silva, Miguel Jacinto, Tiago Pastilha and Pedro Duarte-Mendes to Plos One. We greatly appreciate the helpful comments from the academic editor and reviewers. We have made every effort to incorporate their suggestions and address all their feedback. We believe these revisions have significantly improved the manuscript.

The manuscript was previously submitted to Plos One (PONE-D-25-01668) and changes were made in order to clarify the issues presented by the Academic Editor.

If you need any further information, please feel free to contact us.

Best Regards,

Joana Borges and co-authors

Attachment

Submitted filename: Response to Reviewers_Joana Borges.pdf

pone.0320858.s003.pdf (121.4KB, pdf)

Decision Letter 1

Shabnam ShahAli

13 Feb 2025

PONE-D-25-01668R1Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: A study protocol for a randomized controlled trialPLOS ONE

Dear Dr. Borges,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shabnam ShahAli, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for your good paper with enough information. The changes are acceptable. However, it is better to check out each item in spirit checklist. And it may make your paper more valuable if you add more outcome measures.

Reviewer #2: Dear authors,

Well done. My recommendations were addressed. My decision is now ACCEPTANCE.

Good Luck

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Laleh Abadi marand

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 May 20;20(5):e0320858. doi: 10.1371/journal.pone.0320858.r005

Author response to Decision Letter 2


14 Feb 2025

Dear Academic Editor Shabnam ShahAli,

Dear Reviewers,

We are grateful for the opportunity to resubmit our manuscript to PLOS ONE. The feedback from reviewers was helpful, and we have responded to their comments.

Attached below are the reviewers' comments along with a summary of the changes we made. Additionally, we have submitted an updated version of the manuscript with all revisions highlighted in yellow. Please feel free to reach out if you need any further information.

Journal requirements:

We confirm that the reference list has been thoroughly reviewed and is both complete and accurate.

Review Comments to the Author

Reviewer #1: Thanks for your good paper with enough information. The changes are acceptable. However, it is better to check out each item in spirit checklist. And it may make your paper more valuable if you add more outcome measures.

Authors' response: Thank you very much for your comment and contribution to our paper in order to enhance our work and make it more valuable. Regarding the suggestion to add more outcome measures, we have carefully considered this possibility. However, we believe that the outcomes already included are appropriate and sufficient to address the study objectives and provide relevant results.

The SPIRIT checklist was updated and we added information about the point 5d. We added the section “Author Contributions” to our manuscript in page 13, lines 432-446.

Reviewer #2: Dear authors,

Well done. My recommendations were addressed. My decision is now ACCEPTANCE.

Good Luck

Authors' response: Thank you very much for your comment and contributions.

Joana Borges and Co-authors

Attachment

Submitted filename: Response_to_Reviewers_Joana_Borges_auresp_2.pdf

pone.0320858.s004.pdf (106.3KB, pdf)

Decision Letter 2

Shabnam ShahAli

20 Feb 2025

PONE-D-25-01668R2Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: A study protocol for a randomized controlled trialPLOS ONE

Dear Dr. Borges,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shabnam ShahAli, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The paper is generally well written and the concerns of the previous reviewers have been addressed and appear reasonable.

However, there are some concerns remaining from the statistical design and analysis perspective.

1. Please check other references to be sure that the effect size of 1.079 for the VAS being used for this study’s sample size consideration is realistic. It does appear rather large and based on only one reference.

2. The inflation of 15% for the sample looks rather arbitrary. What is this based on? The sample size is small enough with the assumed large effect size and one does not want to come up short after such an effort.

3. There are three primary endpoints with an overall 0.05 significance level being used for the study. This involves multiple comparisons and thus needs an adjustment to the p-value or the type one error is inflated with multiple endpoints being considered. One may consider a Bonferroni type or other type of correction such as Holm-Bonferroni to the alpha level being used for each test. Likewise, there are three secondary endpoints and one could challenge these results if a level of 0.05 is maintained. Ultimately, this could affect the actual sample size required for the entire study.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 May 20;20(5):e0320858. doi: 10.1371/journal.pone.0320858.r007

Author response to Decision Letter 3


23 Feb 2025

Dear Editor,

My colleagues and I would like to thank you for the opportunity to resubmit our manuscript to PLOS ONE. We found that the academic reviewers’ and editor comments were very helpful, and we have done our best to incorporate all their suggestions and reply to the comments. We believe that this has made a significant contribution to the overall quality of the manuscript.

Our responses are attached at the bottom of this letter. We have also submitted an updated version of our manuscript with all the changes highlighted in yellow. If you require any additional information, please do not hesitate to get in touch with us.

Thank you for considering our manuscript.

On behalf of all authors, yours sincerely,

Joana Borges

Attachment

Submitted filename: Response_to_Reviewers_Joana_Borges_auresp_3.pdf

pone.0320858.s005.pdf (592.2KB, pdf)

Decision Letter 3

Shabnam ShahAli

27 Feb 2025

Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: A study protocol for a randomized controlled trial

PONE-D-25-01668R3

Dear Dr. Borges,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shabnam ShahAli, Ph.D.

Academic Editor

PLOS ONE

Acceptance letter

Shabnam ShahAli

PONE-D-25-01668R3

PLOS ONE

Dear Dr. Borges,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shabnam ShahAli

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Filled SPIRIT checklist.
    pone.0320858.s001.doc (122.5KB, doc)

    (DOC)

    Attachment

    Submitted filename: Response to Reviewers_Joana Borges.docx

    pone.0320858.s002.docx (13.4KB, docx)
    Attachment

    Submitted filename: Response to Reviewers_Joana Borges.pdf

    pone.0320858.s003.pdf (121.4KB, pdf)
    Attachment

    Submitted filename: Response_to_Reviewers_Joana_Borges_auresp_2.pdf

    pone.0320858.s004.pdf (106.3KB, pdf)
    Attachment

    Submitted filename: Response_to_Reviewers_Joana_Borges_auresp_3.pdf

    pone.0320858.s005.pdf (592.2KB, pdf)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES